US Stock MarketDetailed Quotes

SLP Simulations Plus

Watchlist
  • 28.210
  • -2.180-7.17%
Close Jan 8 16:00 ET
  • 27.770
  • -0.440-1.56%
Post 20:01 ET
566.81MMarket Cap70.53P/E (TTM)

About Simulations Plus Company

Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The firm operates through the Software and Services segment. The Software segment offers software products for pharmaceutical research, development, and commercialization of the firm's products. The Services segment focuses on contracted consulting studies for customers and offers services supporting marketplace insight and medical communications for clinical and commercial drug development. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Lancaster, CA.

Company Profile

SymbolSLP
Company NameSimulations Plus
Listing DateJun 18, 1997
Issue Price5.00
Founded1996
CEOMr. Shawn O’Connor
MarketNASDAQ
Employees247
Fiscal Year Ends08-31
Address42505 10th Street West
CityLancaster
ProvinceCalifornia
CountryUnited States of America
Zip Code93534-7059
Phone1-661-723-7723

Company Executives

  • Name
  • Position
  • Salary
  • Shawn O’Connor
  • Chief Executive Officer
  • 1.66M
  • Daniel Szot
  • Chief Revenue Officer
  • 895.07K
  • William Frederick
  • Chief Operating Officer,Chief Financial Officer and Principal Accounting Officer
  • 1.01M
  • Jenna Rouse
  • President, Adaptive Learning and Insights
  • --
  • Steven Chang
  • President, Quantitative Systems Pharmacology Solutions
  • 656.41K
  • Murry Alper
  • President, Medical Communications
  • --
  • John A. DiBella
  • President, PBPK, Regulatory Strategies and Cheminformatics Solutions
  • 661.62K
  • Dr. Daniel Weiner
  • Chairman of the Board
  • 210.07K
  • Dr. Jonathan Chauvin
  • Co-President, Clinical Pharmacology and Pharmacometric Services
  • --
  • Jill Fiedler-Kelly, M.S.
  • Co-President, Clinical Pharmacology and Pharmacometric Services
  • --
  • Dr. John K. Paglia, C.F.A.,C.P.A.,PhD
  • Independent Director
  • 200.07K
  • Dr. Lisa LaVange
  • Independent Director
  • 190.07K
  • Sharlene Evans
  • Independent Director
  • 187.57K
  • Dr. Walter S. Woltosz
  • Independent Director
  • 200.07K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.